Morgan Stanley
-
-
-
-
-
-
-
Biohaven Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares
-
-
-
-
-
-
-
Biohaven Pharma (BHVN) Prices 5.6M Share Offering at $41/sh
-
-
-
-
-
-
-
Biohaven Pharmaceutical Holding (BHVN) PT Lowered to $50 at Morgan Stanley
-
-
-
-
-
-
-
Biohaven Announces Pricing of Public Offering of Common Shares
-
-
-
-
-
-
-
Morgan Stanley Starts Biohaven Pharmaceutical Holding (BHVN) at Overweight
-
-
-
-
224,330 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

